NYSE: PEN

Price 66.15
-0.30 -0.45%
12/09/16
Volume: 218,232
Pricing delayed 20 minutes More >

Investor Overview

Headquartered in Alameda, California, Penumbra, Inc. is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Latest Events

Stay tuned for upcoming events

SEC Filings

Date Filing Type Filing Description Download / View
11/22/2016 4 Statement of Changes in Beneficial Ownership
11/18/2016 8-K Current report filing
11/17/2016 4 Statement of Changes in Beneficial Ownership

Email Alerts

Mailing Lists *


Email Address *

 
Enter the code shown above.

Investor Contact